Paradigm Biocapital Advisors LP Verona Pharma PLC Transaction History

Paradigm Biocapital Advisors LP

  • $2.77 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$11.48 - $17.02 $8.28 Million - $12.3 Million
721,087 New
721,087 $10.4 Million
Q3 2023

Nov 14, 2023
BUY
$16.3 - $22.09 $530,907 - $719,493
32,571 Added 3.64%
926,432 $15.1 Million
Q2 2023

Aug 14, 2023
SELL
$19.41 - $23.43 $1.33 Million - $1.6 Million
-68,500 Reduced 7.12%
893,861 $18.9 Million
Q1 2023

May 15, 2023
BUY
$18.06 - $25.27 $17.4 Million - $24.3 Million
962,361 New
962,361 $19.3 Million

Others Institutions Holding VRNA

# of Institutions
166
Shares Held
68.7M
Call Options Held
704K
Put Options Held
685K
View Full List

About Verona Pharma plc

VRNA Quotes by TradingView
  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $2.17B
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track Paradigm Biocapital Advisors LP Portfolio

Follow Paradigm Biocapital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Biocapital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Biocapital Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email